Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences

被引:40
|
作者
Kim, Bokyung [1 ]
机构
[1] Univ Texas Austin, Dept Econ, Austin, TX 78712 USA
关键词
Prescription drug monitoring program; Must-access PDMP; Opioid; Heroin; Opioid overdose; Opioid epidemic;
D O I
10.1016/j.jhealeco.2020.102408
中图分类号
F [经济];
学科分类号
02 ;
摘要
Although supply-side drug policies that limit access to legal opioids have reduced prescription opioid abuse, growing evidence shows that these policies have had the unintended consequence of increasing use of illegal opioids, including heroin. I add to this literature by studying the consequences of must-access prescription drug monitoring programs (PDMPs), which legally require providers to access a state-level database with a patient's prescription history before prescribing controlled substances under certain circumstances. Using a difference-in-differences specification, I find strong evidence that must-access PDMPs have increased heroin death rates. My estimates indicate that two years after implementation, must-access PDMPs were associated with 0.9 more heroin deaths per 100,000 in a half-year period, relative to control states. My results suggest that even if must-access PDMPs reduce prescription opioid deaths, the decrease is offset by a large increase in illegal opioid deaths. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Impact of a Mandatory Prescription Drug Monitoring Program Check on Emergency Department Opioid Prescribing Rates
    Watson, C. James
    Ganetsky, Michael
    Burke, Ryan C.
    Dizitzer, Yotam
    Leventhal, Evan L.
    Boyle, Katherine L.
    JOURNAL OF MEDICAL TOXICOLOGY, 2021, 17 (03) : 265 - 270
  • [32] Impact of a Mandatory Prescription Drug Monitoring Program Check on Emergency Department Opioid Prescribing Rates
    C. James Watson
    Michael Ganetsky
    Ryan C. Burke
    Yotam Dizitzer
    Evan L. Leventhal
    Katherine L. Boyle
    Journal of Medical Toxicology, 2021, 17 : 265 - 270
  • [33] Alternatives to Opioid Education and a Prescription Drug Monitoring Program Cumulatively Decreased Outpatient Opioid Prescriptions
    Sigal, Adam
    Shah, Ankit
    Onderdonk, Alex
    Deaner, Traci
    Schlappy, David
    Barbera, Charles
    PAIN MEDICINE, 2021, 22 (02) : 499 - 505
  • [34] Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program
    Martello, Jennifer
    Cassidy, Brenda
    Mitchell, Ann
    JOURNAL OF ADDICTIONS NURSING, 2018, 29 (03) : 196 - 202
  • [35] Ensemble learning to predict opioid-related overdose using statewide prescription drug monitoring program and hospital discharge data in the state of Tennessee
    Ripperger, Michael
    Lotspeich, Sarah C.
    Wilimitis, Drew
    Fry, Carrie E.
    Roberts, Allison
    Lenert, Matthew
    Cherry, Charlotte
    Latham, Sanura
    Robinson, Katelyn
    Chen, Qingxia
    McPheeters, Melissa L.
    Tyndall, Ben
    Walsh, Colin G.
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2021, 29 (01) : 22 - 32
  • [36] Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018
    Henry, Stephen G.
    Shev, Aaron B.
    Crow, David
    Stewart, Susan L.
    Wintemute, Garen J.
    Fenlon, Christine
    Wirtz, Stephen J.
    PREVENTIVE MEDICINE, 2021, 153
  • [37] Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children
    Christina M. Theodorou
    Jordan E. Jackson
    Ganesh Rajasekar
    Miriam Nuño
    Kaeli J. Yamashiro
    Diana L. Farmer
    Shinjiro Hirose
    Erin G. Brown
    Pediatric Surgery International, 2021, 37 : 659 - 665
  • [38] Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children
    Theodorou, Christina M.
    Jackson, Jordan E.
    Rajasekar, Ganesh
    Nuno, Miriam
    Yamashiro, Kaeli J.
    Farmer, Diana L.
    Hirose, Shinjiro
    Brown, Erin G.
    PEDIATRIC SURGERY INTERNATIONAL, 2021, 37 (05) : 659 - 665
  • [39] What do PAs need to know about prescription drug monitoring programs?
    Mospan, Geoffrey A.
    Lucas, Austin
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2017, 30 (07): : 11 - 12
  • [40] A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016
    Smith, Nathan
    Martins, Silvia S.
    Kim, June
    Rivera-Aguirre, Ariadne
    Fink, David S.
    Castillo-Carniglia, Alvaro
    Henry, Stephen G.
    Mooney, Stephen J.
    Marshall, Brandon D. L.
    Davis, Corey
    Cerda, Magdalena
    ADDICTION, 2019, 114 (02) : 248 - 258